Role of acid sphingomyelinase in the regulation of mast cell function

Clinical and Experimental Allergy

Volumn 44, Issue 1, 2014, Pages 79-90

  Yang, W ^a   Schmid, E ^a   Nurbaeva, M K ^a   Szteyn, K ^a   Leibrock, C ^a   Yan, J ^a   Schaller, M ^a   Gulbins, E ^b   Shumilina, E ^a   Lang, F ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acid sphingomyelinase; Allergy; Anaphylaxis; Ca2+ channels; Degranulation; KCa3.1; K+ channels

Indexed keywords

AMITRIPTYLINE; BETA N ACETYLHEXOSAMINIDASE; CD34 ANTIGEN; FURA 2; IMMUNOGLOBULIN E; LIPOCORTIN 5; SPHINGOMYELIN PHOSPHODIESTERASE; STEM CELL FACTOR RECEPTOR;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY TEMPERATURE; BONE MARROW; CELL FUNCTION; CELL MATURATION; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE; GENOTYPE; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PATCH CLAMP TECHNIQUE; PERITONEUM LAVAGE; PERITONEUM MAST CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM;

ACID SPHINGOMYELINASE; ALLERGY; ANAPHYLAXIS; CA2+ CHANNELS; DEGRANULATION; K+ CHANNELS; KCA3.1;

ANAPHYLAXIS; ANIMALS; ANTIGENS; CALCIUM; CELL DEGRANULATION; CELL MOVEMENT; ENZYME ACTIVATION; IMMUNOPHENOTYPING; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MAST CELLS; MICE; MICE, KNOCKOUT; PHENOTYPE; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84890808026     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12229     Document Type: Article

References (76)

1. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2:773-86.
2. Kawakami T, Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 2005; 175:4167-73.
3. Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy 2005; 87:111-29.
4. Bradding P. The role of the mast cell in asthma: a reassessment. Curr Opin Allergy Clin Immunol 2003; 3:45-50.
5. Brightling CE, Bradding P, Pavord ID, Wardlaw AJ. New insights into the role of the mast cell in asthma. Clin Exp Allergy 2003; 33:550-6.
6. Askenase PW, Van Loveren H, Kraeuter-Kops S et al. Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J Immunol 1983; 131:2687-94.
7. Conti P, Reale M, Barbacane RC, Panara MR, Bongrazio M, Theoharides TC. Role of lipoxins A4 and B4 in the generation of arachidonic acid metabolites by rat mast cells and their effect on [3H]serotonin release. Immunol Lett 1992; 32:117-23.
8. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-86.
9. Van Loveren H, Meade R, Askenase PW. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med 1983; 157:1604-17.
10. Asada H, Linton J, Katz SI. Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. J Invest Dermatol 1997; 108:406-11.
11. Biedermann T, Kneilling M, Mailhammer R et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192:1441-52.
12. Galli SJ, Nakae S. Mast cells to the defense. Nat Immunol 2003; 4:1160-2.
13. Hill PB, MacDonald AJ, Thornton EM, Newlands GF, Galli SJ, Miller HR. Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay. Immunology 1996; 87:326-33.
14. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 2005; 102:6467-72.
15. Nakae S, Suto H, Iikura M et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176:2238-48.
16. Bradding P, Conley EC. Human mast cell ion channels. Clin Exp Allergy 2002; 32:979-83.
17. Bradding P, Okayama Y, Kambe N, Saito H. Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J Leukoc Biol 2003; 73:614-20.
18. Buess M, Engler O, Hirsch HH, Moroni C. Search for oncogenic regulators in an autocrine tumor model using differential display PCR: identification of novel candidate genes including the calcium channel mtrp6. Oncogene 1999; 18:1487-94.
19. Dernick G. Alvarez dT, Lindau M, Exocytosis of single chromaffin granules in cell-free inside-out membrane patches. Nat Cell Biol 2003; 5:358-62.
20. Duffy SM, Lawley WJ, Conley EC, Bradding P. Resting and activation-dependent ion channels in human mast cells. J Immunol 2001; 167:4261-70.
21. Duffy SM, Leyland ML, Conley EC, Bradding P. Voltage-dependent and calcium-activated ion channels in the human mast cell line HMC-1. J Leukoc Biol 2001; 70:233-40.
22. Kahr H, Schindl R, Fritsch R et al. CaT1 knock-down strategies fail to affect CRAC channels in mucosal-type mast cells. J Physiol 2004; 557:121-32.
23. Mazurek N, Berger G, Pecht I. A binding site on mast cells and basophils for the anti-allergic drug cromolyn. Nature 1980; 286:722-3.
24. Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med 2004; 200:137-47.
25. Sel S, Rost BR, Yildirim AO et al. Loss of classical transient receptor potential 6 channel reduces allergic airway response. Clin Exp Allergy 2008; 38:1548-58.
26. Bradding P. Mast cell ion channels. Chem Immunol Allergy 2005; 87:163-78.
27. + channel iKCa1 in human mast cells. FASEB J 2005; 19:1006-8.
28. + influx and degranulation in human lung mast cells. J Allergy Clin Immunol 2004; 114:66-72.
29. Bradding P. Novel approaches to the inhibition of mast cells in allergic disease. Clin Exp Allergy 2008; 38:704-8.
30. + and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6. Am J Respir Crit Care Med 2012; 185:160-70.
31. Herz J, Pardo J, Kashkar H et al. Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes. Nat Immunol 2009; 10:761-8.
32. Dhami R, He X, Schuchman EH. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cell Physiol Biochem 2010; 26:749-60.
33. Becker KA, Grassme H, Zhang Y, Gulbins E. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell Physiol Biochem 2010; 26:57-66.
34. Kuebler WM, Yang Y, Samapati R, Uhlig S. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 2010; 26:29-40.
35. Li X, Becker KA, Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem 2010; 26:41-8.
36. Lang PA, Schenck M, Nicolay JP et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13:164-70.
37. Walter S, Fassbender K. Spingolipids in multiple sclerosis. Cell Physiol Biochem 2010; 26:49-56.
38. Kornhuber J, Tripal P, Reichel M et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 2010; 26:9-20.
39. Arboleda G, Huang TJ, Waters C, Verkhratsky A, Fernyhough P, Gibson RM. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur J Neurosci 2007; 25:3030-8.
40. de la Monte SM. Insulin resistance and Alzheimer's disease. BMB Rep 2009; 42:475-81.
41. Tong M, Neusner A, Longato L, Lawton M, Wands JR, de la Monte SM. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J Alzheimers Dis 2009; 17:827-44.
42. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008; 29:381-402.
43. Zhao H, Przybylska M, Wu IH et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007; 56:1210-8.
44. Zigmond E, Zangen SW, Pappo O et al. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am J Physiol Endocrinol Metab 2009; 296:E72-8.
45. Alessenko AV. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. Membr Cell Biol 2000; 13:303-20.
46. Dimanche-Boitrel MT, Rebillard A, Gulbins E. Ceramide in chemotherapy of tumors. Recent Pat Anticancer Drug Discov 2011; 6:284-93.
47. Eliyahu E, Shtraizent N, Shalgi R, Schuchman EH. Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility. Cell Physiol Biochem 2012; 30:735-48.
48. Lang F, Ullrich S, Gulbins E. Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 2011; 15:1061-71.
49. Li X, Gulbins E, Zhang Y. Oxidative stress triggers Ca-dependent lysosome trafficking and activation of acid sphingomyelinase. Cell Physiol Biochem 2012; 30:815-26.
50. Lupescu A, Shaik N, Jilani K et al. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 2012; 30:876-88.
51. Morad SA, Cabot MC. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 2013; 13:51-65.
52. Qadri SM, Bauer J, Zelenak C et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 2011; 28:339-46.
53. Syed I, Szulc ZM, Ogretmen B, Kowluru A. L- threo -C(6)-pyridinium-ceramide Bromide, a Novel Cationic Ceramide, Induces NADPH Oxidase Activation, Mitochondrial Dysfunction and Loss in Cell Viability in INS 832/13 beta-cells. Cell Physiol Biochem 2012; 30:1051-8.
54. Young MM, Kester M, Wang HG. Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 2013; 54:5-19.
55. Itakura A, Tanaka A, Aioi A, Tonogaito H, Matsuda H. Ceramide and sphingosine rapidly induce apoptosis of murine mast cells supported by interleukin-3 and stem cell factor. Exp Hematol 2002; 30:272-8.
56. Mirghomizadeh F, Winoto-Morbach S, Orinska Z, Lee KH, Schutze S, Bulfone-Paus S. Intracellular IL-15 controls mast cell survival. Exp Cell Res 2009; 315:3064-75.
57. Santana P, Pena LA, Haimovitz-Friedman A et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996; 86:189-99.
58. Grassme H, Jendrossek V, Riehle A et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 2003; 9:322-30.
59. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981; 391:85-100.
60. + channel KCa3.1. J Immunol 2008; 180:8040-7.
61. Szteyn K, Schmid E, Nurbaeva MK et al. Expression and functional significance of the Ca-activated Cl(-) channel ANO6 in dendritic cells. Cell Physiol Biochem 2012; 30:1319-32.
62. Barry PH, Lynch JW. Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 1991; 121:101-17.
63. Schmid E, Bhandaru M, Nurbaeva MK et al. SGK3 regulates Ca entry and migration of dendritic cells. Cell Physiol Biochem 2012; 30:1423-35.
64. + entry into mast cells. Cell Physiol Biochem 2010; 26:699-706.
65. Baba Y, Nishida K, Fujii Y, Hirano T, Hikida M, Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol 2008; 9:81-8.
66. Mathes C, Fleig A, Penner R. Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J Biol Chem 1998; 273:25020-30.
67. Olivera A, Rivera J. Sphingolipids and the balancing of immune cell function: lessons from the mast cell. J Immunol 2005; 174:1153-8.
68. Hewson CA, Watson JR, Liu WL, Fidock MD. A differential role for ceramide kinase in antigen/FcepsilonRI-mediated mast cell activation and function. Clin Exp Allergy 2011; 41:389-98.
69. Field KA, Holowka D, Baird B. Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci USA 1995; 92:9201-5.
70. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev 1997; 77:901-30.
71. Shimizu T, Owsianik G, Freichel M, Flockerzi V, Nilius B, Vennekens R. TRPM4 regulates migration of mast cells in mice. Cell Calcium 2009; 45:226-32.
72. Schmid E, Gu S, Yang W et al. Serum- and glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation. Am J Physiol Cell Physiol 2013; 304:C49-55.
73. Nishida K, Yamasaki S, Ito Y et al. Fc{epsilon}RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 2005; 170:115-26.
74. Sullivan R, Burnham M, Torok K, Koffer A. Calmodulin regulates the disassembly of cortical F-actin in mast cells but is not required for secretion. Cell Calcium 2000; 28:33-46.
75. Xuan NT, Shumilina E, Kempe DS, Gulbins E, Lang F. Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides. J Neuroimmunol 2010; 219:81-9.
76. Shah C, Yang G, Lee I, Bielawski J, Hannun YA, Samad F. Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1. J Biol Chem 2008; 283:13538-48.